 Our president and founder Since the mid 1970's David Himmelberger has been involved in quality of life and economic evaluations. He participated in the planning and analysis of the landmark clinical trials with Auranofin, an oral gold-treatment for rheumatoid arthritis. From this experience it was clear that the quantitative measurement of health outcomes would play a major role in the future of health care throughout the world. After many years as a biostatistician at Stanford University and experience in the pharmaceutical industry in strategic planning, international marketing research and outcomes evaluation, Health Outcomes Group was founded in 1987. | We meet the demands of today and lead the direction for tomorrow Health Outcomes Group is uniquely qualified to meet both your qualitative and quantitative challenges of the future. We build long-lasting bridges between you and your customers... A global outlook on problems and their solutions Our staff and associates around the world are sensitive to different cultures built upon centuries of history. We will work together with you, using common methods to achieve coordinated global objectives... |
